Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Updownsidewayson Oct 14, 2016 1:02am

74 Views

Post# 25342368

RE:POP Goes the MJ BUBBLE

I'm pretty sure they're in the business of renting "turn key" growing facilites to 4 growers that grow marijuana. So yeah, not sure if that means they're technically in the MJ business, but doesn't matter as they should still benefit from MJ

ezemoney wrote: And funny as it is, this company is not even in the mj business but is in the greenhouse
business lol but when people get crazed, reality distorts in their mind.

Bullboard Posts

Global Tungsten Market and Supply Security